Top Markets
#1 ADO Protocol ADO Protocol +195.51%
#2 Islamic Coin Islamic Coin +155.46%
#3 GoPlus Security GoPlus Security +59.58%
#4 Verus Coin Verus Coin +33.00%
#5 Starpower Starpower +27.12%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +15.11%
#8 Status Status +14.31%
#9 The Black Bull The Black Bull +12.35%
#10 o1.exchange o1.exchange +11.85%
Coin of the day
ADO Protocol ADO Protocol
설정
언어
한국어
통화
USD
테마
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
주식 순위 #33298
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
주가
$0.4264
마지막 동기화: 2022-09-14
시가총액
$7.93M
변동 (1일)
-16.44%
변동 (1년)
0.00%
국가
US
거래 Caladrius Biosciences, Inc. (CLBS)

카테고리

Healthcare
Caladrius Biosciences, Inc. (CLBS)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
Caladrius Biosciences, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
Caladrius Biosciences, Inc.의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE